ResMed lifts FY profit

Sleep disorder equipment maker says soft US sales weighed on June quarter.

Sleep disorder equipment maker ResMed has posted a lift in profit despite soft sales in the US.

ResMed, which makes sleep disorder and respiratory equipment, has announced a 12% rise in full-year profit to $US345.3m ($A373.6m).

In the three months to June, the company's profit was $US87.7 million ($A94.9m), up from $US73m ($A79m) recorded in fourth quarter 2013.

However, ResMed chief executive Mick Farrell says the fourth quarter results weren't as good as expected.

"Our fourth quarter results were lower than anticipated, the result of softer sales in the Americas, partially offset by good growth in our international markets," he said.

He said a $US6.3m ($A6.82m) restructure of the company's commercial and research and development teams, including employee termination benefits, impacted on the quarter.

The San Diego-based company's shares on the Australian Securities Exchange were 5.08% lower at $5.23 at 2.55pm (AEST), against a benchmark index fall of 1.45%.

ResMed began in 1989, selling a device developed at the University of Sydney to treat sleep apnea.

It now develops and sells a range of devices around the world to treat sleep and respiratory disorders.

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles